Zacks Research Issues Optimistic Estimate for AXSM Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Zacks Research lifted their Q2 2025 earnings per share (EPS) estimates for Axsome Therapeutics in a research note issued to investors on Monday, May 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of ($1.20) per share for the quarter, up from […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Zacks Research lifted their Q2 2025 earnings per share (EPS) estimates for Axsome Therapeutics in a research note issued to investors on Monday, May 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of ($1.20) per share for the quarter, up from […]
